These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 16788944

  • 21. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y, Noguchi T, Takeno S, Kimura Y, Okubo M, Kawahara K.
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [Abstract] [Full Text] [Related]

  • 22. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 23. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [Abstract] [Full Text] [Related]

  • 24. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis.
    Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H, Siewert JR.
    Cancer; 1998 Sep 01; 83(5):858-66. PubMed ID: 9731887
    [Abstract] [Full Text] [Related]

  • 25. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
    Kato H, Miyazaki T, Fukai Y, Nakajima M, Sohda M, Takita J, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H.
    J Surg Oncol; 2003 Sep 01; 84(1):24-30. PubMed ID: 12949987
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K.
    Cancer; 2001 Mar 01; 91(5):964-71. PubMed ID: 11251948
    [Abstract] [Full Text] [Related]

  • 27. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Ochiai T.
    Oncol Rep; 2007 Oct 01; 18(4):867-71. PubMed ID: 17786348
    [Abstract] [Full Text] [Related]

  • 28. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M, Fukui H, Ono Y, Sekikawa A, Ichikawa K, Tomita S, Imai Y, Imura J, Hiraishi H, Fujimori T.
    Pathobiology; 2007 Oct 01; 74(1):15-21. PubMed ID: 17496429
    [Abstract] [Full Text] [Related]

  • 29. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
    Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D.
    Ann Surg Oncol; 2007 Sep 01; 14(9):2621-7. PubMed ID: 17570016
    [Abstract] [Full Text] [Related]

  • 30. The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
    Tannehill-Gregg SH, Kusewitt DF, Rosol TJ, Weinstein M.
    Vet Pathol; 2004 May 01; 41(3):278-82. PubMed ID: 15133179
    [Abstract] [Full Text] [Related]

  • 31. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma.
    Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T, Kuwano H.
    Int J Cancer; 2003 Mar 20; 104(2):161-6. PubMed ID: 12569570
    [Abstract] [Full Text] [Related]

  • 32. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.
    Fang WK, Gu W, Li EM, Wu ZY, Shen ZY, Shen JH, Wu JY, Pan F, Lv Z, Xu XE, Huang Q, Xu LY.
    Hum Pathol; 2010 Oct 20; 41(10):1456-65. PubMed ID: 20621329
    [Abstract] [Full Text] [Related]

  • 33. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
    Chen XY, Li JS, Liang QP, He DZ, Zhao J.
    Chin Med J (Engl); 2008 May 20; 121(10):881-6. PubMed ID: 18706200
    [Abstract] [Full Text] [Related]

  • 34. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma.
    Faried A, Nakajima M, Sohda M, Miyazaki T, Kato H, Kuwano H.
    Eur J Surg Oncol; 2005 May 20; 31(4):410-4. PubMed ID: 15837049
    [Abstract] [Full Text] [Related]

  • 35. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
    Lee KB, Jeon JH, Choi I, Kwon OY, Yu K, You KH.
    Biochem Biophys Res Commun; 2008 Feb 22; 366(4):905-9. PubMed ID: 18082619
    [Abstract] [Full Text] [Related]

  • 36. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, Wang F, Tucker S, Zhong B, Wang D.
    Jpn J Clin Oncol; 2009 Oct 22; 39(10):644-50. PubMed ID: 19648590
    [Abstract] [Full Text] [Related]

  • 37. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Saito H, Minamiya Y, Satoh S, Murata K, Suzuki T, Ogawa J.
    Ann Surg Oncol; 2009 Sep 22; 16(9):2479-85. PubMed ID: 19495883
    [Abstract] [Full Text] [Related]

  • 38. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu YC, Kuo SY, Hsieh MJ, Hsueh C.
    J Surg Oncol; 2012 Mar 22; 105(3):288-92. PubMed ID: 21932407
    [Abstract] [Full Text] [Related]

  • 39. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
    Banas MC, Parks WT, Hudkins KL, Banas B, Holdren M, Iyoda M, Wietecha TA, Kowalewska J, Liu G, Alpers CE.
    J Histochem Cytochem; 2007 Mar 22; 55(3):275-85. PubMed ID: 17142805
    [Abstract] [Full Text] [Related]

  • 40. Prognostic variables in thoracic esophageal squamous cell carcinoma.
    Lin CS, Chang SC, Wei YH, Chou TY, Wu YC, Lin HC, Wang LS, Hsu WH.
    Ann Thorac Surg; 2009 Apr 22; 87(4):1056-65. PubMed ID: 19324127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.